Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload

• Published in: Cardiovascular research 2021-11, Vol.117 (12), p.2474-2488
• Main Authors: Lambert, Mélanie, Mendes-Ferreira, Pedro, Ghigna, Maria-Rosa, LeRibeuz, Hélène, Adão, Rui, Boet, Angèle, Capuano, Véronique, Rucker-Martin, Catherine, Brás-Silva, Carmen, Quarck, Rozenn, Domergue, Valérie, Vachiéry, Jean-Luc, Humbert, Marc, Perros, Frédéric, Montani, David, Antigny, Fabrice
• Format: Article
• Language: English
• Subjects: Animals; Arterial Pressure; Biochemistry, Molecular Biology; Cardiology and cardiovascular system; Disease Models, Animal; Human health and pathology; Life Sciences; Mutation; Nerve Tissue Proteins; Nerve Tissue Proteins - genetics; Nerve Tissue Proteins - metabolism; Potassium Channels, Tandem Pore Domain; Potassium Channels, Tandem Pore Domain - genetics; Potassium Channels, Tandem Pore Domain - metabolism; Pulmonary Arterial Hypertension; Pulmonary Arterial Hypertension - etiology; Pulmonary Arterial Hypertension - genetics; Pulmonary Arterial Hypertension - metabolism; Pulmonary Arterial Hypertension - physiopathology; Pulmonary Artery; Pulmonary Artery - metabolism; Pulmonary Artery - physiopathology; Rats; Rats, Transgenic; Signal Transduction; Vascular Remodeling; Ventricular Dysfunction, Left; Ventricular Dysfunction, Left - complications; Ventricular Dysfunction, Left - genetics; Ventricular Dysfunction, Left - metabolism; Ventricular Dysfunction, Left - physiopathology; Ventricular Function, Left; Ventricular Pressure
• ISSN: 0008-6363; 1755-3245
• DOI: 10.1093/cvr/cvab016

Pulmonary hypertension (PH) is a common complication of left heart disease (LHD, Group 2 PH) leading to right ventricular (RV) failure and death. Several loss-of-function (LOF) mutations in KCNK3 were identified in pulmonary arterial hypertension (PAH, Group 1 PH). Additionally, we found that KCNK3 dysfunction is a hallmark of PAH at pulmonary vascular and RV levels. However, the role of KCNK3 in the pathobiology of PH due to LHD is unknown. We evaluated the role of KCNK3 on PH induced by ascending aortic constriction (AAC), in WT and Kcnk3-LOF-mutated rats, by echocardiography, RV catheterization, histology analyses, and molecular biology experiments. We found that Kcnk3-LOF-mutation had no consequence on the development of left ventricular (LV) compensated concentric hypertrophy in AAC, while left atrial emptying fraction was impaired in AAC-Kcnk3-mutated rats. AAC-animals (WT and Kcnk3-mutated rats) developed PH secondary to AAC and Kcnk3-mutated rats developed more severe PH than WT. AAC-Kcnk3-mutated rats developed RV and LV fibrosis in association with an increase of Col1a1 mRNA in right ventricle and left ventricle. AAC-Kcnk3-mutated rats developed severe pulmonary vascular (pulmonary artery as well as pulmonary veins) remodelling with intense peri-vascular and peri-bronchial inflammation, perivascular oedema, alveolar wall thickening, and exaggerated lung vascular cell proliferation compared to AAC-WT-rats. Finally, in lung, right ventricle, left ventricle, and left atrium of AAC-Kcnk3-mutated rats, we found a strong increased expression of Il-6 and periostin expression and a reduction of lung Ctnnd1 mRNA (coding for p120 catenin), contributing to the exaggerated pulmonary and heart remodelling and pulmonary vascular oedema in AAC-Kcnk3-mutated rats. Our results indicate that Kcnk3-LOF is a key event in the pathobiology of PH due to AAC, suggesting that Kcnk3 channel dysfunction could play a potential key role in the development of PH due to LHD.